Cargando…

Using the Montreal Cognitive Assessment Scale to screen for dementia in Chinese patients with Parkinson's Disease

BACKGROUND: Dementia is one of the most distressing and burdensome health problems associated with Parkinson's Disease (PD). The Montreal Cognitive Assessment scale (MoCA) is widely used to screen for dementia in PD patients, but the appropriate diagnostic cutoff score when used with Chinese PD...

Descripción completa

Detalles Bibliográficos
Autores principales:	CHEN, Ling, YU, Cuiyu, FU, Xiaosu, LIU, Weiguo, HUA, Ping, ZHANG, Ning, KUO, Shenghan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Department of the Shanghai Archives of Psychiatry 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4054575/ https://www.ncbi.nlm.nih.gov/pubmed/24991170 http://dx.doi.org/10.3969/j.issn.1002-0829.2013.05.005

Ejemplares similares

The Chinese (Cantonese) Montreal Cognitive Assessment in Patients with Subcortical Ischemic Vascular Dementia
por: You, Jin-song, et al.
Publicado: (2011)

Comparison of Montreal cognitive assessment and Mattis dementia rating scale in the preoperative evaluation of subthalamic stimulation in Parkinson’s disease
por: Gülke, Eileen, et al.
Publicado: (2022)

Accuracy of the Short-Form Montreal Cognitive Assessment Chinese Versions
por: Tan, Ji-ping, et al.
Publicado: (2021)

Application of the Chinese Version of the Montreal Cognitive Assessment-Basic for Assessing Mild Cognitive Impairment in Parkinson’s Disease
por: Xu, Qian, et al.
Publicado: (2021)

Dementia Risk Prediction in a Longitudinal Geriatric Parkinson’s Disease Cohort: Evaluation and Application of the Montreal Parkinson Risk of Dementia Scale
por: Bohn, Linzy, et al.
Publicado: (2023)

Validity of the Montreal Cognitive Assessment and the HIV Dementia Scale in the assessment of cognitive impairment in HIV-1 infected patients
por: Janssen, M. A. M., et al.
Publicado: (2015)

Validation of the cognitive performance scale of the interRAI‐PAC and montreal cognitive assessment
por: Ou, Jibing, et al.
Publicado: (2022)

Montreal Cognitive Assessment — Single Cutoff Achieves Screening Purpose
por: Yeung, Pui Yu, et al.
Publicado: (2020)

Montreal Cognitive Assessment scale in patients with Parkinson Disease with normal scores in the Mini-Mental State Examination
por: Vásquez, Krisly Arguedas, et al.
Publicado: (2019)

Comparative Study of Two Short-Form Versions of the Montreal Cognitive Assessment for Screening of Post-Stroke Cognitive Impairment in a Chinese Population
por: Wei, Jingjing, et al.
Publicado: (2020)

Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson's Disease
por: Henderson, Emily J., et al.
Publicado: (2016)

Floor and ceiling effects on the Montreal Cognitive Assessment in patients with Parkinson’s disease in Brazil
por: Koshimoto, Brenda Hanae Bentes, et al.
Publicado: (2023)

Cognitive screening for adult psychiatric outpatients: Comparison of the Cognivue(®) to the Montreal Cognitive Assessment
por: Rose, Amanda F, et al.
Publicado: (2021)

Evaluation of the Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in SLE
por: Raghunath, Sudha, et al.
Publicado: (2021)

Validation of the Argentine version of the Montreal Cognitive Assessment Test (MOCA): A screening tool for Mild Cognitive Impairment and Mild Dementia in Elderly
por: Serrano, Cecilia M., et al.
Publicado: (2020)

Cut-off points of the Portuguese version of the Montreal Cognitive Assessment for cognitive evaluation in Parkinson’s disease
por: Almeida, Kelson James, et al.
Publicado: (2019)

Accuracy of Machine Learning Using the Montreal Cognitive Assessment for the Diagnosis of Cognitive Impairment in Parkinson’s Disease
por: Jeon, Junbeom, et al.
Publicado: (2022)

Montreal cognitive assessment reflects cognitive reserve
por: Kang, Jae Myeong, et al.
Publicado: (2018)

Comparison of Rapid Cognitive Screen against Montreal Cognitive Assessment in screening for cognitive impairment in the old and old‐old
por: Chen, Matthew Zhixuan, et al.
Publicado: (2022)

The validation of the Beijing version of the Montreal Cognitive Assessment in Chinese patients undergoing hemodialysis
por: Tian, Ru, et al.
Publicado: (2020)

Chinese-Language Montreal Cognitive Assessment for Cantonese or Mandarin Speakers: Age, Education, and Gender Effects
por: Zheng, Ling, et al.
Publicado: (2012)

Improved predictive ability of the Montreal Cognitive Assessment for diagnosing dementia in a community-based study
por: Hsu, Jung-Lung, et al.
Publicado: (2015)

Chinese version of Montreal Cognitive Assessment Basic for discrimination among different severities of Alzheimer’s disease
por: Huang, Lin, et al.
Publicado: (2018)

Optimal Cutoff Scores for Dementia and Mild Cognitive Impairment in the Brazilian Version of the Montreal Cognitive Assessment among the Elderly
por: Pinto, Tiago C.C., et al.
Publicado: (2019)

Screening for cognitive impairment with the Montreal Cognitive Assessment in Chinese patients with acute mild stroke and transient ischaemic attack: a validation study
por: Zuo, Lijun, et al.
Publicado: (2016)

Montreal cognitive assessment in primary sjogren’s syndrome: A brief screening tool
por: Kurtuluş, Fatma, et al.
Publicado: (2019)

DEVELOPMENT OF A SWEDISH SHORT VERSION OF THE MONTREAL COGNITIVE ASSESSMENT FOR COGNITIVE SCREENING IN PATIENTS WITH STROKE
por: ABZHANDADZE, Tamar, et al.
Publicado: (2023)

Longitudinal Measurement Properties of the Montreal Cognitive Assessment
por: Andersson, Björn, et al.
Publicado: (2021)

Feasibility of Cognitive Functions Screened With the Montreal Cognitive Assessment in Determining ADL Dependence Early After Stroke
por: Abzhandadze, Tamar, et al.
Publicado: (2018)

Comparison of the Greek Version of the Quick Mild Cognitive Impairment Screen and Montreal Cognitive Assessment in Older Adults
por: Messinis, Lambros, et al.
Publicado: (2022)

Some aspects of the validity of the Montreal Cognitive Assessment (MoCA) for evaluating cognitive impairment in Brazilian patients with Parkinson's disease
por: Tumas, Vitor, et al.
Publicado: (2016)

The Montreal cognitive assessment as a cognitive screening tool in sickle cell disease: Associations with clinically significant cognitive domains
por: Early, Macy L., et al.
Publicado: (2022)

Application and Revision of Montreal Cognitive Assessment in China's Military Retirees with Mild Cognitive Impairment
por: Zhai, Yali, et al.
Publicado: (2016)

Comparison of Alternate and Original Items on the Montreal Cognitive Assessment
por: Lebedeva, Elena, et al.
Publicado: (2016)

Concordance of the Montreal cognitive assessment with standard neuropsychological measures
por: Vogel, Sally J., et al.
Publicado: (2015)

The Montreal Cognitive Assessment Test: A Useful Tool in Screening of Cognitive Impairment in Patients With Systemic Lupus Erythematosus
por: Paez-Venegas, Nicolas, et al.
Publicado: (2019)

Comparison of Oxford Cognitive Screen and Montreal Cognitive Assessment feasibility in the stroke unit setting. A pilot study
por: Brambilla, Michela, et al.
Publicado: (2021)

Screening for brain fog: Is the montreal cognitive assessment an effective screening tool for neurocognitive complaints post-COVID-19?
por: Lynch, Sean, et al.
Publicado: (2022)

Montreal Cognitive Assessment as Screening Measure for Mild and Major Neurocognitive Disorder in a Chilean Population
por: Bello-Lepe, Sebastian, et al.
Publicado: (2020)

Validation of the Conversion between the Mini-Mental State Examination and Montreal Cognitive assessment in Korean Patients with Parkinson’s Disease
por: Kim, Ryul, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dgk79ocabn8r83j3v56hfu8jqa